medicine-news-1/biocryst-announces-partnerships-for-peramivir-for-influenza-outside-the-u-s--57160-4/;+health+history;+medical+history.html
| We're sorry, that page (http://www.bio-medicine.org/medicine-news-1/biocryst-announces-partnerships-for-peramivir-for-influenza-outside-the-u-s--57160-4/;+health+history;+medical+history.html) was not found. Search medicine news 1 biocryst announces partnerships for peramivir for influenza outside the u s 57160 4 ;+health+history;+medical+history html at Google Search medicine news 1 biocryst announces partnerships for peramivir for influenza outside the u s 57160 4 ;+health+history;+medical+history html at Yahoo Search medicine news 1 biocryst announces partnerships for peramivir for influenza outside the u s 57160 4 ;+health+history;+medical+history html at Msn |
(Date:12/4/2009)CORALVILLE, Iowa, Dec. 4 Vivakor, Inc. (OTC Bulletin Board: VIVK) today confirmed that its shareholders of record on December 1, 2009 will receive the dividend of shares of common stock of HealthAmer
(Date:12/3/2009)MELVILLE, N.Y., Dec. 3 Nikon Corporation, an innovator of advanced optical instruments, announced today that it has signed a licensing agreement with Harvard University granting Nikon the rights to u
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6[0] Vivakor Confirms Record Date of Stock Dividend[0] Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope[0] Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock[0] Reportlinker Adds Neurostimulation - A Global Market Perspective
(Date:12/4/2009)FREMONT, Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, 2009, it filed its First Amended Plan of Reorganization and related amended Disclosure Statement wit
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Mpex Reports Positive Phase II Results with Aeroquin Delivered by PARI Pharmas eFlow Technology 57095 1Mpex Reports Positive Phase II Results with Aeroquin Delivered by PARI Pharmas eFlow Technology 57095 2Mpex Reports Positive Phase II Results with Aeroquin Delivered by PARI Pharmas eFlow Technology 57095 3Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice 57092 1Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice 57092 2Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice 57092 3Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice 57092 4Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice 57092 5Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 1Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 2Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 3Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 4Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 5| Copyright © 2003-2007 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |